Table 4.
Inflammatory cytokines | N |
Δ Baseline -7 h [fold change ± SE] (pg/dL) |
DE Effect Δ Baseline-7 h [fold change] (95% confidence interval) |
N |
Δ Baseline -22 h [fold change ± SE] (pg/dL) |
DE Effect Δ Baseline-22 h [fold change] (95% confidence interval) |
||
---|---|---|---|---|---|---|---|---|
Filtered air | DE-200 | Filtered air | DE-200 | |||||
P-values | P-values | |||||||
Myeloperoxidase |
16 |
0.2 ± 0.2 |
0.4 ± 0.3 |
0.2 |
16 |
0.01 ± 0.2 |
0.4 ± 0.2 |
0.4 |
(95% CI: -1.1 to 0.7) |
(95% CI: -0.2 to 0.9) |
|||||||
P=0.7 |
P=0.2 |
|||||||
Adiponectin |
16 |
0.1 ± 0.2 |
-0.02 ± 0.1 |
0.1 |
15 |
-0.1 ± 0.2 |
0.2 ± 0.1 |
0.3 |
(95% CI: -0.4 to 0.6) |
(95% CI: -0.3 to 0.8) |
|||||||
P=0.6 |
P=0.3 |
|||||||
MMP-9 |
14 |
0.0 ± 0.1 |
0.3 ± 0.2 |
0.3 |
15 |
0.01 ± 0.1 |
-0.1 ± 0.1 |
-0.1 |
|
|
|
|
(95% CI: -0.2 to 0.8) |
|
|
|
(95% CI: -0.6 to 0.3) |
|
|
|
|
P=0.2 |
|
|
|
P=0.5 |
MCP-1 |
15 |
-0.2 ± 0.1 |
-0.2 ± 0.1 |
-0.01 |
15 |
-0.2 ± 0.1 |
-0.2 ± 0.1 |
-0.01 |
|
|
|
|
(95% CI: -0.3 to 0.2) |
|
|
|
(95% CI: -0.2 to 0.2) |
|
|
|
|
P=0.9 |
|
|
|
P=0.9 |
VEGF |
15 |
0.1 ± 0.1 |
0.1 ± 0.1 |
0.02 |
16 |
0.1 ± 0.1 |
0.1 ± 0.1 |
0.01 |
(95% CI: -0.2 to 0.2) |
(95% CI: -0.1 to 0.1) |
|||||||
P=0.6 |
P=0.7 |
|||||||
Pro-BNP |
5 |
0.3 ± 0.2 |
-0.2 ± 0.3 |
-0.4 |
6 |
0.1 ± 0.3 |
-0.1 ± 0.3 |
-0.2 |
(95% CI: -1.5 to 0.7) |
(95% CI: -1.0 to 0.6) |
|||||||
P=0.9 |
P=0.1 |
|||||||
TNF-α |
15 |
-0.1 ± 0.04 |
-0.1 ± 0.1 |
0.02 |
15 |
0.0 ± 0.1 |
-0.03 ± 0.1 |
-0.03 |
|
|
|
|
(95% CI: -1.4 to 0.2) |
|
|
|
(95% CI: -0.2 to 0.1) |
|
|
|
|
P=0.8 |
|
|
|
P=0.5 |
IL-1β |
9 |
-0.3 ± 0.2 |
0.1 ± 0.1 |
0.5 |
11 |
-0.2 ± 0.3 |
0.1 ± 0.3 |
0.3 |
|
|
|
|
(95% CI: -0.01 to 1) |
|
|
|
(95% CI: -1.1 to 2 ) |
|
|
|
|
P=0.06 |
|
|
|
P=0.9 |
IL-6 |
11 |
-0.04 ± 0.1 |
1.1 ± 0.7 |
1.1 |
8 |
0.2 ± 0.1 |
-0.1 ± 0.1 |
-0.3 |
(95% CI: -0.7 to 3) |
(95% CI: -0.6 to 0.1) |
|||||||
P=0.6 |
P=0.1 |
|||||||
IL-8 |
15 |
-0.3 ± 0.1 |
-0.2 ± 0.2 |
0.1 |
16 |
-0.2 ± 0.1 |
-0.3 ± 0.2 |
-0.1 |
(95% CI: -0.3 to 0.6) |
(95% CI: -0.5 to 0.3) |
|||||||
P=0.8 |
P=0.9 |
|||||||
IL-10 | 15 | -0.3 ± 0.1 | -0.01 ± 0.1 | 0.3 |
16 | -0.1 ± 0.1 | 0.1 ± 0.1 | 0.2 |
(95% CI: -0.1 to 0.6) |
(95% CI: -0.3 to 0.6) |
|||||||
P=0.2 | P=0.5 |
Data are shown for the mean log2 differences from pre-exposure to 7 hours (Δ Baseline-7 h) and 22 hours (Δ Baseline-22 h) of exposure initiation. DE effect refers to the effect attributable to DE calculated as (Post –pre DE exposure)-(Post-pre FA exposure) for the log2 transformed values to obtain fold changes. Positive difference indicates that the change in given marker was relatively more positive over DE-exposure interval, as compared to change over FA exposure interval. SE - Standard Error; CI - Confidence Interval.